AI주식인사이트AI Stock Insight
C

지씨셀

144510KOSDAQ그외 기타 전문, 과학 및 기술 서비스업

43.9 / 100

Reference Date: 2026-04-13

Financial Score10.0 / 40
News Sentiment16.9 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is undervalued vs. peers but ROE is below the industry average. Declined 13.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

GC Cell is a company primarily engaged in the development and commercialization of cell therapies, specimen testing, cord blood banking, bio-logging, and CDMO services. The company is focusing on the development of NK and T cell therapies and is advancing research on next-generation CAR-NK and CAR-T treatments.

Number of Employees

806people

Average Salary

48.9M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 59.134.0Point
PBR
1.92Industry Average 1.944.0Point

In line with industry avg

ROE
-83.81Industry Average 1.530.0Point

Well below industry avg

Debt Ratio
18.04Industry Average 16.092.0Point

Higher than industry avg (caution)

Trend 2023~20250.0 / 10 points
Revenue Growth Rate
0.0 / 3

Avg ▼6.1% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼279.8% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -33.0% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position5.0Point

52w mid range (52%)

Current 23,100Won52-week high 27,50052-week low 18,280
1-month return1.0Point

1m -12.99% (falling)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 0Neutral 3Negative 0
  • Neutral정기주주총회결과2026-03-24
  • Neutral사업보고서 (2025.12)2026-03-16
  • Neutral감사보고서제출2026-03-16